AMMF - The Cholangiocarcinoma Charity, Stansted, UK.
Department of Surgery, Faculty of Medicine, Khon Kaen University, 40002 Khon Kaen, Thailand.
Recent Results Cancer Res. 2023;219:349-359. doi: 10.1007/978-3-031-35166-2_12.
Although cholangiocarcinoma (CCA) or bile duct cancer is considered rare, worldwide it is the second most common primary liver cancer. The incidence is increasing globally, and mortality is high owing to its aggressiveness, late diagnosis, and refractory nature. In this chapter, the awareness of cholangiocarcinoma in the West and in Southeast Asia, particularly Thailand, is explored. The background to this cancer in each region is described, and the challenges faced by both by healthcare professionals and patients are uncovered. Although there is a growing number of organisations working at every level in each region to improve the situation for those with cholangiocarcinoma, there remains little awareness of the public health importance of this cancer. However, it is with health agencies and those at government level that hopes for an improved future for all those with cholangiocarcinoma must lie.
尽管胆管癌（CCA）或胆管癌被认为很少见，但在全球范围内，它是第二常见的原发性肝癌。由于其侵袭性、晚期诊断和难治性，发病率在全球范围内呈上升趋势，死亡率也很高。在本章中，探讨了西方和东南亚，特别是泰国对胆管癌的认识。描述了每个地区这种癌症的背景，并揭示了医疗保健专业人员和患者所面临的挑战。尽管在每个地区，越来越多的组织在各个层面上为改善胆管癌患者的状况而努力，但公众对这种癌症的重要性仍然知之甚少。然而，胆管癌患者的未来的希望必须寄托在卫生机构和政府层面上。
